Target Trial Emulation
Everything on Aqrab tagged Target Trial Emulation — grouped into one landing page so readers can go deeper by problem family instead of bouncing around the archive blind.
Target Trial Emulation Cannot Randomize Clinical Judgment: A Pertussis Study Audit
A practical target-trial emulation audit using an infant pertussis study. Check clinical-judgment confounding, propensity-score overlap, endpoint timing, sparse outcomes, and claim strength.
Vaccine Effectiveness Without Matching: Why Calendar Time Comes Before Pairing
A practical guide to calendar time in vaccine-effectiveness studies. Learn how changing uptake and infection hazards alter risk sets, estimands, and target-trial conclusions.
Comparator Selection in Observational Studies: Why the Control Group Changes the Question
A practical guide to comparator selection in observational studies. Learn how active comparators change the estimand, confounding structure, and interpretation of real-world evidence.
Treatment History Is Part of the Estimand: Why Starting and Switching Answer Different Questions
A practical guide to treatment history in target trial emulation. Learn why initiators and switchers define different estimands, how sequential trials align switching decisions, and why relative and absolute risk must travel together.
Treatment-Timing Effects: When “Earlier Is Better” Needs a Fair Clock
A practical guide to auditing earlier-is-better claims in observational studies. Test time zero, treatment strategies, evolving clinical decisions, positivity, and timing curves before reading a treatment gradient as biological.
How to Audit a Target-Trial Emulation: Four Decisions Behind One Mortality Estimate
A practical target-trial emulation audit using a dialysis mortality study. Translate a day-91 landmark, sustained-treatment threshold, competing event, and center context into the question actually estimated.
Heterogeneous Treatment Effects: Validate the Average Effect Before Trusting the Subgroups
A practical guide to validating heterogeneous treatment-effect claims in target trial emulation. Learn why a failed average-effect benchmark should stop a subgroup story, how subgroup effects must reconcile with their parent estimate, and what reviewers should demand before trusting personalized treatment claims.
Benchmarking Target Trial Emulation: When a Trial Copy Never Checks It Can Reproduce the Known Answer
A practical guide to benchmarking target trial emulation for clinical researchers. Covers why benchmark replication matters, what it cannot prove, and what reviewers should demand before trusting an observational extension.
Repeated Eligibility in Target Trial Emulation: When One Patient Quietly Enters the Trial Again
A practical guide to repeated eligibility in target trial emulation for clinical researchers. Covers re-entry rules, overlapping follow-up, carryover, and what reviewers should demand before trusting a sequential-trial analysis.
Time Zero Alignment: When Your Cohort Starts Counting Before Treatment Does
A practical guide to time zero alignment for clinical researchers. Covers eligibility, treatment assignment, delayed initiation, immortal time, and what reviewers should demand before trusting a real-world effect estimate.
Grace Periods in Target Trial Emulation: Clinical Realism or Future Information in Disguise?
A practical guide to grace periods in target trial emulation for clinical researchers. Covers when a grace window is defensible, when it becomes immortal time in formalwear, and what reviewers should demand before trusting the result.
Clone-Censor-Weight: The Target Trial Fix That Still Breaks When You Use It Casually
A practical guide to clone-censor-weight for clinical researchers. Covers when the design is needed, how cloning and artificial censoring work, where immortal time bias reappears, and what reviewers should demand before trusting a target trial emulation.
Target Trial Emulation: A Practical Guide for Clinical Researchers
The framework that bridges observational data and causal claims — by asking what RCT you wish you had. Covers protocol specification, time zero alignment, clone-censor-weight, immortal time bias, and reporting.
Explore more topics
These are ranked by how often they appear alongside Target Trial Emulation, so the next click is more likely to be useful than random.